Back to search
FDAFDA · Food and drugs·Recall number D-0447-2017

Mesalamine, U.S.P. [CAS 89-57-6] Cambrex Charles City, Inc. Charles City, IA packaged in double lined PE liners inside Poly-lined cardboard drums. Net weight 40 kg

Published February 1, 2017 · Recall initiated: May 20, 2014

Summary

FDA records drug Class II recall D-0447-2017, published February 1, 2017 and initiated May 20, 2014. Recalling firm: Cambrex Charles City Inc; Status: Terminated; Reported quantity: 2351.12 pound container; Lot: Code 1661911; Batch 1340; Exp. 03/17. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Particulate Matter: Stainless steel in a chemical reactor dissolved into the API solution and was detected in the finished product.

What to do

Voluntary: Firm initiated

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Cambrex Charles City Inc
Distributor
Product distributed solely to the state of Minnesota.
Lot
Code 1661911; Batch 1340; Exp. 03/17
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Mesalamine, U.S.P. [CAS 89-57-6] Cambrex Charles City, Inc. Charles City, IA packaged in double lined PE liners inside Poly-lined cardboard drums. Net weight 40 kg recalled?

Yes. FDA published recall D-0447-2017 on February 1, 2017. Reported hazard: Presence of Particulate Matter: Stainless steel in a chemical reactor dissolved into the API solution and was detected in the finished product.

What should I do if I have this product?

Voluntary: Firm initiated